Abstracts tagged "fibromyalgia"

Abstract Number: 160 • 2017 ACR/ARHP Annual Meeting
Fibromyalgia Screening Form in the Diagnosis of Concomitant Fibromyalgia
Robert S. Katz¹ and Jessica L. Polyak², ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates S.C., Chicago, IL
Background/Purpose: We have found that patients with a variety of rheumatic diseases who have concomitant fibromyalgia more frequently fail therapies for the underlying inflammatory rheumatic…
Abstract Number: 2115 • 2017 ACR/ARHP Annual Meeting
Mast Cell Activation Features in Ehlers-Danlos/Joint Hypermobility Patients: A Retrospective Analysis in Light of an Emerging Disease Cluster
Dave Lee¹ and Eric Mueller², ¹Arthritis Northwest, PLLC, Spokane, WA, ²Discus Analytics LLC., Spokane, WA
Background/Purpose: Mast cells are immune cells often residing in connective tissue, best known for their role in allergic and anaphylactic responses1. Mast cell activation syndrome…
Abstract Number: 843 • 2017 ACR/ARHP Annual Meeting
The Role of Personality in Patients with Fibromyalgia
Andrew Seto¹, Teresa Wu¹, Lori Lyn Price^2,3,4,5, Xingyi Han⁶, William F. Harvey¹ and Chenchen Wang⁷, ¹Tufts Medical Center, Boston, MA, ²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ³Clinical Care Research, Tufts Medical Center, Boston, MA, ⁴Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ⁵Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, ⁶Public Health and Community Medicine, Tufts University, Boston, MA, ⁷Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: Previous studies investigating the potential associations between personality and clinical symptoms in fibromyalgia (FM) patients have found mixed results. The purpose of this study…
Abstract Number: 2247 • 2017 ACR/ARHP Annual Meeting
Secondary Fibromyalgia Is Not Associated with Higher Likelihood of Patient-Physician Discordance in Global Assessment in Patients with Osteoarthritis and Rheumatoid Arthritis
Isabel Castrejón, Shakeel M. Jamal and Najia Shakoor, Division of Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Pain is the strongest driver of patient-physician discordance in global assessment in patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Having secondary fibromyalgia (FM),…
Abstract Number: 1101 • 2017 ACR/ARHP Annual Meeting
Systematic Physician Assessment Beyond Inflammation in Routine Rheumatology Care Using Visual Analog Scale Scores for Inflammation, Damage, and Distress to Document Patient Status and Support Clinical Decisions: Analysis of Inter-Rater Reliability
Shakeel M. Jamal¹, Theodore Pincus², Isabel Castrejón², Jacquelin R. Chua¹, Aman Kugasia¹, Juan Schmukler¹, Stacy Weinberg¹ and Joel A. Block³, ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: A physician global estimate of patient status (DOCGL) on a 0-10 visual analog scales (VAS) is as effective as any rheumatoid arthritis (RA) Core…
Abstract Number: 2992 • 2017 ACR/ARHP Annual Meeting
Curbing the Opioid Epidemic: Predictors of Opioid Use in Juvenile Fibromyalgia Syndrome
Sabrina Gmuca¹, Rui Xiao², Andrea M. Knight³, David D. Sherry¹, Pamela F. Weiss⁴ and Jeffrey S. Gerber⁵, ¹Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ²Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ³Division of Rheumatology, Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Division of Rheumatology, Center for Pediatric Clincial Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ⁵Children's Hospital of Philadelphia, Philadelphia, PA
Background/Purpose: Despite the lack of evidence to support the use of opioids in the treatment of adult fibromyalgia syndrome, approximately 30% of patients receive an…
Abstract Number: 1411 • 2016 ACR/ARHP Annual Meeting
An Electronic MDHAQ (multidimensional health assessment questionnaire) Beyond an Electronic RAPID (routine assessment of patient index data): 21.3% of Rheumatoid Arthritis Patients Identified As Having Secondary Fibromyalgia Versus 3.5% By Clinicians
Theodore Pincus and Nathaniel Cook, Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: A major impediment to use of patient questionnaires in routine clinical care has been the absence of electronic entry for patients and for doctors…
Abstract Number: 1767 • 2016 ACR/ARHP Annual Meeting
Poor Body Image in Lupus: Is It Disease Activity, Damage, Sleep, Pain, Fatigue, Stress, Function, Medications, Depression or Fibromyalgia?
Stacy Weinberg¹, Nisarg Gandhi², Meenakshi Jolly³, Winston Sequeira² and Shilpa Arora², ¹Rush University Medical Center, Chicago, IL, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Rush, Chicago, IL
Background/Purpose: Patients with systemic lupus erythematosus (SLE) have poorer body image (BI) than age matched controls. Few studies have been done looking at the effect…
Abstract Number: 1791 • 2016 ACR/ARHP Annual Meeting
Loss of Elbow Hyperextension in Females with Early Rheumatologic Disease Was Common in Systemic Lupus Erythematosus and Rheumatoid Arthritis but Rare in Fibromyalgia
John P. Case¹, Heidi Tucker² and Congbin Wang³, ¹Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, ²Rush Medical College, Chicago, IL, ³Internal medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
Background/Purpose: The elbow extension angle (ELB) is commonly given as 180o although most healthy females exhibit hyperextension(1). The loss of hyperextension (LOH) in a…
Abstract Number: 2080 • 2016 ACR/ARHP Annual Meeting
Three Simple Tests to Raise the Index of Suspicion for Fibromyalgia in Primary Care
Amanda W. St. John¹, Jonathan H. Aebischer², Robert M. Bennett³, Madeleine J. Sanford², Kaitlin Z. Haws⁴ and Kim D. Jones³, ¹Anesthesiology and Pain Medicine, Oregon Health & Science University, Portland, OR, ²Department of Family Medicine, Oregon Health & Science University, Portland, OR, ³Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, ⁴Department of Internal Medicine and Geriatrics, Oregon Health & Science University, Portland, OR
Background/Purpose: 356 patients were studied (mean age 50 ± 16.3 years, 70% female). Chart review revealed that 53 (15%) of these patients carried a…
Abstract Number: 52 • 2016 ACR/ARHP Annual Meeting
Pregabalin Dose-Response for Sleep Quality and Pain Response in Fibromyalgia: A Post-Hoc Analysis of Three Randomized Trials
Andrew Clair¹, Ed Whalen¹, Neal Thomas¹ and Lynne Pauer², ¹Pfizer, New York, NY, ²Pfizer, Groton, CT
Background/Purpose: Pregabalin is often administered for treatment of fibromyalgia (FM) at daily doses lower than approved by the US Food and Drug Administration (starting dose…
Abstract Number: 33 • 2016 ACR/ARHP Annual Meeting
Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients
Thomas Romano, Private Practice, Martins Ferry, OH
Background/Purpose: Low levels of Insulin-dependent growth factor 1 (IGF-1) have been described in Fibromyalgia (FM) patients, suggesting that they have adult growth hormone (GH) deficiency.…
Abstract Number: 2200 • 2016 ACR/ARHP Annual Meeting
Association of Active Commuting and Physical Activity in Women with Fibromyalgia
Manuel Herrador-Colmenero¹, Fernando Estévez-López¹, Víctor Segura-Jiménez¹, Inmaculada C Álvarez-Gallardo¹, Alberto Soriano-Maldonado¹, Daniel Camiletti-Moirón^1,2, Virginia A Aparicio¹, Manuel Delgado-Fernández¹ and Palma Chillón¹, ¹University of Granada, Granada, Spain, ²University of Cádiz, Cádiz, Spain
Background/Purpose: Fibromyalgia symptomatology results in a low functional capacity1, limiting the daily activities and the quality of life of the patients2. Walking for commuting is…
Abstract Number: 54 • 2016 ACR/ARHP Annual Meeting
Patients with Fibromyalgia in General Have Higher Self-Report Questionnaire Scores Than Patients with Rheumatoid Arthritis: Implications for Clinical Trials and Clinical Research
Theodore Pincus¹, Isabel Castrejón¹, Joel Block² and Nathaniel Cook¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Division of Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Patients with rheumatoid arthritis (RA) who are included in clinical trials generally are selected for measures indicating high disease activity, such as more than…
Abstract Number: 42 • 2016 ACR/ARHP Annual Meeting
Small Fibre Neuropathy Biopsies (SFN) in Primary Fibromyalgia Revealed Predominant Association with Metabolic Syndrome (in addition to other known treatable causes of SFN) but No Clear Distinction Related to Biopsy Results
Euthalia Roussou¹, Johnathan Chan², Istvan Bodi³ and Aleksandar Radunivics², ¹Rheumatology, Dr, London, United Kingdom, ²Neurologist, London, United Kingdom, ³Department of Clinical Neuropathology, London, United Kingdom
Background/Purpose: To assess patients with primary fibromyalgia (pFM) for small fibre neuropathy (SFN) and to correlate biopsy results between groups and with known causes of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].